Cellulitis, unspecified
ICD-10 L03.90 is a billable code used to indicate a diagnosis of cellulitis, unspecified.
Cellulitis, unspecified (ICD-10 code L03.90) refers to a common bacterial skin infection characterized by inflammation of the skin and subcutaneous tissues. Clinically, it presents as a red, swollen area that feels warm and tender to the touch, often accompanied by systemic symptoms such as fever and chills. The infection typically occurs when bacteria enter through a break in the skin, which can be due to cuts, insect bites, or other skin injuries. The most commonly affected areas include the legs and face, although cellulitis can occur anywhere on the body. Disease progression can lead to severe complications if left untreated, including abscess formation and systemic infection. Diagnostic considerations include a thorough clinical examination and, in some cases, imaging studies to rule out deeper infections or abscesses. Laboratory tests may be performed to identify the causative organism, although empirical treatment is often initiated based on clinical suspicion. Accurate diagnosis and timely intervention are crucial to prevent complications and ensure effective management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L03.90 covers cases of cellulitis where the specific site of infection is not documented. This may include generalized cellulitis without further specification of the affected area.
L03.90 should be used when the clinical documentation does not specify the site of cellulitis. If the site is known, related codes such as L03.91 or L03.92 should be selected for more accurate coding.
Documentation should include a clear description of the clinical presentation, any relevant history of skin injury, and the absence of specific site identification. Notes on treatment response and any systemic symptoms should also be included.
